All the above evidence about APOE gene might give a plausible explanation for the sex-dimorphism of the association of PLA2G7 promoter methylation with aging in CHD, although cautions need to be taken without direct supportive evidence. This evidence concerns the gene PLA2G7 and coronary artery disorder.